We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Polyethylene terephthalate nanoplastics promote gastric cancer progression by inhibiting the TNF-α/JAK1/STAT1 signaling pathway and shaping an immunosuppressive microenvironment
Original title: Polyethylene terephthalate nanoplastics promote gastric cancer progression by inhibiting the TNF-α/JAK1/STAT1 signaling pathway and shaping an immunosuppressive microenvironment
Summary
Tiny plastic particles from PET plastic (commonly used in bottles and food packaging) may do more than just contaminate our bodies—new research in mice and lab-grown cells shows they can actually help stomach cancer grow faster and resist chemotherapy. These nanoplastics appear to weaken the immune system's ability to fight tumors and block a key cancer-suppressing pathway in the body. While this study was done in mice and cells rather than humans, it adds to growing evidence that chronic exposure to microplastics isn't just an environmental issue—it could be a real risk factor for cancer progression.
Polyethylene terephthalate (PET), one of the most widely produced plastics used in food packaging, has emerged as a pervasive source of microplastic exposure in humans, with recent evidence confirming its presence in the human stomach. However, the biological consequences of PET nanoplastics (PET-NPs) on gastric carcinogenesis remain largely unexplored. In this study, we systematically investigated the effects of PET-NPs on gastric cancer progression and the underlying molecular and immunological mechanisms. PET-NPs were readily internalized by gastric cancer cells, leading to enhanced cell proliferation, migration, and resistance to Oxaliplatin, accompanied by suppression of apoptosis and immunogenic cell death. In vivo validation using a mouse subcutaneous tumor model further demonstrated that PET-NPs significantly promoted tumor growth. Integrated mechanistic analyses combining transcriptomics, network toxicology, and western blotting revealed that PET-NPs exhibited strong binding affinity to tumor necrosis factor-α (TNF-α), resulting in inhibition of the downstream JAK1/STAT1 signaling pathway. Moreover, PET-NPs profoundly remodeled the tumor immune microenvironment by promoting M2 macrophage polarization, reducing CD8+ T cell infiltration, upregulating immune checkpoint molecules TIGIT and PD-1, and suppressing key antitumor cytokines, including IFN-γ and TNF-α. Collectively, these findings demonstrate that PET-NPs act as a previously underrecognized environmental risk factor that accelerates gastric cancer progression through direct molecular interference and immune suppression, highlighting the potential public health implications of chronic microplastic exposure.